INTRIVICI, Chiara
 Distribuzione geografica
Continente #
NA - Nord America 1.423
EU - Europa 741
AS - Asia 135
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 1
Totale 2.303
Nazione #
US - Stati Uniti d'America 1.422
FI - Finlandia 179
IT - Italia 157
UA - Ucraina 127
DE - Germania 111
CN - Cina 100
GB - Regno Unito 44
IE - Irlanda 44
SE - Svezia 36
RU - Federazione Russa 19
KR - Corea 12
IN - India 11
BE - Belgio 7
RO - Romania 6
FR - Francia 5
IR - Iran 4
EU - Europa 3
GR - Grecia 2
AZ - Azerbaigian 1
BG - Bulgaria 1
BR - Brasile 1
CA - Canada 1
CH - Svizzera 1
HK - Hong Kong 1
HU - Ungheria 1
MY - Malesia 1
NL - Olanda 1
PH - Filippine 1
SG - Singapore 1
TR - Turchia 1
UZ - Uzbekistan 1
VN - Vietnam 1
Totale 2.303
Città #
Fairfield 196
Woodbridge 130
Ashburn 129
Ann Arbor 124
Chandler 121
Houston 103
Wilmington 99
Jacksonville 74
Seattle 71
Cambridge 60
Dublin 44
Palermo 39
Medford 34
Nanjing 31
New York 22
Princeton 19
Altamura 18
Tulsa 16
Boardman 15
Lawrence 13
Beijing 12
Des Moines 12
San Diego 12
Seongnam 12
Ludwigshafen am Rhein 10
Nanchang 9
Changsha 8
Jinan 8
Kumar 8
Tianjin 8
Brussels 7
Dearborn 7
Milan 7
Shenyang 6
London 5
Reggio Calabria 5
San Mateo 5
Bremen 4
Hebei 4
Saint Petersburg 4
Venice 4
Helsinki 3
Jiaxing 3
Mazara del Vallo 3
Phoenix 3
Tehran 3
Verona 3
Auburn Hills 2
Düsseldorf 2
Hangzhou 2
Hanover 2
Kilburn 2
Kunming 2
Los Angeles 2
Ningbo 2
Pune 2
Redwood City 2
San Paolo di Civitate 2
Washington 2
Zhengzhou 2
Amsterdam 1
Arco 1
Augusta 1
Aversa 1
Baku 1
Central District 1
Edinburgh 1
Haikou 1
Hanoi 1
Indiana 1
Islington 1
Jinhua 1
Leawood 1
Levanto 1
Moscow 1
Norwalk 1
Nuremberg 1
Nürnberg 1
Orange 1
Pantai 1
Redmond 1
Regente Feijo 1
San Francisco 1
Sesto Fiorentino 1
Singapore 1
Tabriz 1
Toronto 1
Trabzon 1
Wuhan 1
Totale 1.588
Nome #
4843delC of the BRCA1 gene is a possible founder mutation in Southern Italy (Sicily). 260
Aurora-A overexpression as an early marker of reflux-related columnar mucosa and Barrett's oesophagus. 215
Gastrointestinal stromal tumors (GISTs): focus on histopathological diagnosis and biomolecular features 188
Aberrant methylation within RUNX3 CpG island associated with the nuclear and mitochondrial microsatellite instability in sporadic gastric cancers. Results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 183
BRCA1 genetic testing in 106 breast and ovarian cancer families from southern Italy (Sicily): a mutation analyses. 161
Molecular detection of TP53, Ki-Ras and p16INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis. Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 159
Gemcitabine (GEM) plus oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX-4) in patients with advanced gastric cancer. 154
The use of zoledronic acid in patients with bone metastases from prostate carcinoma: effect on analgesic response and bone metabolism biomarkers 144
A case of guillain-barre syndrome in a patient with non small cell lung cancer treated with chemotherapy 140
Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study. 120
“Serum HER-2/neu (s-HER2) levels evaluation in breast cancer (BC) patients (PTS)” 92
Weekly Paclitaxel (T) and pegylated liposomal Doxorubicin (PLD) as first line treatment in metastatic breast cancer (MBC) patients.VII CONGRESSO NAZIONALE G.O.I.M. ROMA 23-25 Giugno 2004 75
Low dose oral chemotherapy for hormone refractory prostate carcinoma estramustine phosphate versus estramustine phosphate and etoposide. A Randomized phase II study of GSTU foundation 73
Pegylated Liposomal Doxorubicin and weekly paclitaxel as first line treatment in metastatic breast cancer 70
A case report of inflammatory pseudotumor of the liver 67
Autoimmunity predicts prolonged survival in colon cancer patients undergoing GOLFIG biochemotherapy. 66
The use of pegylated liposomal doxorubicin (PLD) in association with weekly paclitaxel as second line therapy in metastatic bladder carcinoma: final results 62
La terapia adiuvante nel carcinoma del colon: un update della lettaratura 57
The use of somatostatin analogues in metastatic hormone refractory and chemo resistant prostate cancer with neuroendocrine differentiation. 56
Totale 2.342
Categoria #
all - tutte 6.609
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.609


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019118 0 0 0 0 0 0 0 0 0 0 59 59
2019/2020621 64 24 37 59 69 68 73 39 61 64 41 22
2020/2021300 20 24 9 33 38 13 21 19 40 23 29 31
2021/2022233 4 68 6 9 6 3 20 7 25 28 18 39
2022/2023303 36 55 1 41 44 43 8 26 32 2 10 5
2023/2024127 4 21 12 11 9 43 16 8 0 3 0 0
Totale 2.342